Overview

Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The present protocol is a dose-finding and toxicity study in preparation of a randomised study comparing current standard treatment CSA/prednisolone with the new combination CSA/prednisolone/everolimus.
Phase:
Phase 1
Details
Lead Sponsor:
University Hospital Tuebingen
Treatments:
Cyclosporine
Cyclosporins
Everolimus
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Sirolimus